Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-18 Sale | 2026-08-18 8:29 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 4,767 | $32.03 | $152,690 | 25,655 (Direct) | View |
| 2026-08-18 Sale | 2026-08-18 8:28 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 12,567 | $32.03 | $402,528 | 124,557 (Direct) | View |
| 2026-08-18 Sale | 2026-08-18 8:27 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 2,861 | $32.03 | $91,639 | 21,225 (Direct) | View |
| 2026-08-03 Sale | 2026-08-05 4:17 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 7,176 | $29.04 | $208,385 | 20,422 (Direct) | View |
| 2026-07-01 Sale | 2026-07-06 4:10 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 7,228 | $32.66 | $236,068 | 27,598 (Direct) | View |
| 2026-06-16 Sale | 2026-06-18 4:18 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 1,457 | $29.95 | $43,637 | 18,086 (Direct) | View |
| 2026-06-01 Sale | 2026-06-03 5:33 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 1,795 | $30.58 | $54,891 | 34,826 (Direct) | View |
| 2026-05-01 Sale | 2026-05-05 4:18 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 2,243 | $32.79 | $73,548 | 36,621 (Direct) | View |
| 2026-04-01 Sale | 2026-04-03 4:12 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 1,838 | $32.66 | $60,029 | 38,864 (Direct) | View |
| 2026-03-20 Sale | 2026-03-24 4:19 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 9,293 | $33.69 | $313,038 | 19,543 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 6:01 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 14,311 | $31.92 | $456,835 | 123,737 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 6:00 pm | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 4,578 | $32.14 | $147,145 | 10,172 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 5:58 pm | Stoke Therapeutics Inc. | STOK | Hoitt Jason Chief Patient Officer | 3,712 | $32.14 | $119,311 | 10,276 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 5:57 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 8,895 | $32.14 | $285,901 | 28,836 (Direct) | View |
| 2026-03-13 Sale | 2026-03-17 5:23 pm | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 605 | $36.8 | $22,264 | 22,216 (Indirect Direct) | View |
| 2026-03-10 Sale | 2026-03-12 4:57 pm | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Interim Executive Chair | 4,355 | $40 | $174,214 | 150,035 (Direct) | View |
| 2026-03-10 Sale | 2026-03-12 4:56 pm | Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director | 33,243 | $39.74 | $1,320,964 | 283,302 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:28 pm | Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director | 7,229 | $39.66 | $286,715 | 316,545 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-14 Exercise | 2026-08-18 8:29 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 10,000 | $0 | 25,655 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 8:28 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 26,250 | $0 | 124,557 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 8:27 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 6,000 | $0 | 21,225 (Direct) | View |
| 2026-07-16 Gift | 2026-07-17 4:37 pm | N/A 2029-09-09 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director | 303,190 | $0 | 151,595 (Direct) | View |
| 2026-07-15 Option Award | 2026-07-17 4:35 pm | N/A 2036-07-14 | Stoke Therapeutics Inc. | STOK | McCauley Thomas Chief Scientific Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:33 pm | N/A 2036-06-02 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 17,786 | $0 | 17,786 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:31 pm | N/A 2036-06-02 | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 17,786 | $0 | 17,786 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:30 pm | N/A 2036-06-02 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 17,786 | $0 | 17,786 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:29 pm | N/A 2036-06-02 | Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director | 17,786 | $0 | 17,786 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:27 pm | N/A 2036-06-02 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 17,786 | $0 | 17,786 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:26 pm | N/A 2036-06-02 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director | 17,786 | $0 | 17,786 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:24 pm | N/A 2036-06-02 | Stoke Therapeutics Inc. | STOK | Burstein Jennifer Director | 17,786 | $0 | 17,786 (Direct) | View |
| 2026-04-03 Option Award | 2026-04-07 7:09 pm | N/A 2036-04-02 | Stoke Therapeutics Inc. | STOK | Kahn Clare Director | 30,782 | $0 | 30,782 (Direct) | View |
| 2026-03-19 Exercise | 2026-03-19 6:01 pm | N/A 2028-12-11 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 1,365 | $0 | 123,737 (Direct) | View |
| 2026-03-19 Exercise | 2026-03-19 6:01 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 1,365 | $2.19 | 123,737 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 5:26 pm | N/A 2029-03-15 | Stoke Therapeutics Inc. | STOK | Hoitt Jason Chief Patient Officer | 10,000 | $0 | 43,988 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 5:26 pm | N/A 2029-03-15 | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 14,750 | $0 | 59,000 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 5:25 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 33,850 | $0 | 118,998 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 5:24 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 61,750 | $0 | 198,874 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 5:23 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 25,475 | $0 | 93,206 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 4:57 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Interim Executive Chair | 3,955 | $8.33 | 150,035 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 4:57 pm | N/A 2034-03-19 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Interim Executive Chair | 3,955 | $0 | 150,035 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:25 pm | N/A 2036-02-16 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 100,000 | $0 | 100,000 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:24 pm | N/A 2036-02-16 | Stoke Therapeutics Inc. | STOK | SMITH IAN F Chief Executive Officer | 322,000 | $0 | 322,000 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:22 pm | N/A 2036-02-16 | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:21 pm | N/A 2036-02-16 | Stoke Therapeutics Inc. | STOK | Hoitt Jason Chief Patient Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:20 pm | N/A 2036-02-16 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 88,000 | $0 | 88,000 (Direct) | View |